Preventing Surgical-Site Infections in Nasal Carriers ofStaphylococcus aureus
Author(s) -
L. Bode,
Jan Kluytmans,
Heiman Wertheim,
Diana Bogaers,
Christina M. J. E. VandenbrouckeGrauls,
R. Roosendaal,
Annet Troelstra,
Adrienne T.A. Box,
Andreas Voß,
Ingeborg van der Tweel,
Alex van Belkum,
Henri A. Verbrugh,
Martine De Vos
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0808939
Subject(s) - mupirocin , medicine , staphylococcus aureus , chlorhexidine , placebo , relative risk , confidence interval , staphylococcal infections , surgery , methicillin resistant staphylococcus aureus , randomized controlled trial , nose , pathology , dentistry , alternative medicine , biology , bacteria , genetics
Nasal carriers of Staphylococcus aureus are at increased risk for health care-associated infections with this organism. Decolonization of nasal and extranasal sites on hospital admission may reduce this risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom